Total HCG Test · Blood

A positive home pregnancy test gives you a yes or no. A quantitative blood test for hCG (human chorionic gonadotropin) gives you an exact number. That number opens a window into how your pregnancy is developing, weeks before an ultrasound can show you anything.

This is the molecule that makes every pregnancy test work. Your placenta begins producing it almost immediately after a fertilized egg implants in the uterine wall. Its concentration changes so rapidly in early pregnancy that a single measurement can estimate gestational age, and two measurements 48 hours apart can reveal whether the pregnancy is progressing normally.

How HCG Works in Your Body

HCG is a protein hormone made up of two connected chains, called the alpha and beta subunits. Your body also uses the same alpha chain in other hormones, including LH (luteinizing hormone), FSH (follicle stimulating hormone), and TSH (thyroid stimulating hormone). But the beta chain is unique to hCG, and that unique chain is what pregnancy tests detect.

In early pregnancy, hCG's primary job is keeping the corpus luteum alive. The corpus luteum is a temporary structure in your ovary that produces progesterone, the hormone that maintains the uterine lining and supports the embryo during the first several weeks. Without hCG, the corpus luteum would break down, progesterone would drop, and the pregnancy would fail.

After about the first 8 to 10 weeks, the placenta takes over progesterone production and hCG levels begin to decline. This creates a characteristic pattern: a rapid exponential rise in the first weeks, a peak in the late first trimester, and then a gradual decline to a lower plateau for the rest of pregnancy. A study of 443 normal pregnancies confirmed this trajectory and showed that earlier reports of a "secondary rise" in the third trimester were artifacts of older, less specific laboratory tests.

Tracking Early Pregnancy Health

The speed at which your hCG rises in early pregnancy is one of the most useful pieces of clinical information available before ultrasound can show a heartbeat. In a healthy pregnancy, hCG roughly doubles every 48 to 72 hours during the first several weeks. When that doubling time is slower than expected, it can signal problems. A study of 256 women with first-trimester complications found that serial hCG measurements reliably distinguished normal pregnancies from ectopic pregnancies and miscarriages, with most abnormal pregnancies showing levels that were either too low or rising too slowly.

A meta-analysis examining the best ways to evaluate pregnancies where no gestational sac is visible on ultrasound (called a pregnancy of unknown location) found that serial hCG measurements, specifically the ratio of two values taken 48 hours apart, outperformed any single reading for identifying ectopic pregnancies. In a separate study of 76 women, a single total hCG measurement distinguished ectopic from viable pregnancy with about 86% discrimination (where 100% would be perfect separation between the two groups). A related measurement, free beta-hCG alone, performed slightly better at about 91%, but neither test on its own could distinguish ectopic from miscarriage.

In women undergoing IVF (in vitro fertilization), where the exact date of conception is known, even a single early measurement carries significant predictive weight. A study of nearly 7,000 women found that higher beta-hCG levels (a closely related measurement) at the initial post-transfer blood draw strongly predicted full-term live birth, with very low levels suggesting the pregnancy was unlikely to continue.

Low hCG in the late first trimester also carries information about fetal growth. In a study of nearly 8,000 pregnancies, lower hCG concentrations at this stage were linked to lower birth weight and higher risk of the baby being small for gestational age. This association differed between male and female fetuses, with the pattern more pronounced in pregnancies carrying girls.

Both Extremes Carry Risks

HCG is not a simple "higher is better" marker. Low levels in the late first trimester are linked to reduced fetal growth and smaller babies, but very high levels relative to gestational age have also been associated with pregnancy complications. What matters is whether your level falls within the expected range for your gestational week and is rising at the right pace.

Abnormal hCG is also one component of prenatal screening for chromosomal conditions. Research involving pregnancies affected by fetal chromosome abnormalities found that maternal hCG levels tend to be unusually high or low compared to expectations. Combined with other blood markers and ultrasound measurements, hCG contributes to risk estimates that help guide decisions about further diagnostic testing, with a false positive rate of about 1.35% in one early screening study.

HCG Beyond Pregnancy

Outside of pregnancy, your body still produces tiny amounts of hCG. The pituitary gland, a small structure at the base of the brain, releases it in brief, rhythmic pulses in both men and women. A study of normal adults confirmed this, showing that pituitary hCG production varies with the menstrual cycle. In non-pregnant adults, these levels are normally very low, often below the detection threshold of standard pregnancy tests.

The exception is postmenopausal women. As estrogen drops and the pituitary becomes more active (reflected in rising FSH, or follicle stimulating hormone), hCG from the pituitary can reach detectable levels. A study of 259 non-pregnant women found that concentrations up to about 14 mIU/mL should be considered normal in women over 55, and up to about 8 mIU/mL in women aged 41 to 55. Using the standard pregnancy cutoff of 5 mIU/mL in these age groups would mislabel many healthy women as having a positive result.

HCG also serves as a tumor marker. Certain cancers, particularly gestational trophoblastic disease (abnormal growth of placental tissue, including molar pregnancies and a rare cancer called choriocarcinoma), produce large amounts of hCG. Germ cell tumors, cancers that arise from reproductive cells in the testes or ovaries, can also secrete it. In bladder cancer, elevated levels of total hCG beta (a measurement that captures all forms of the beta subunit, closely related to total hCG) at or above 2 IU/L independently predicted worse outcomes in a study of 235 patients receiving chemotherapy.

Reference Ranges

The most important factor in interpreting an hCG result is whether you are pregnant and, if so, how far along. The ranges below apply to non-pregnant adults and come from a study of 259 non-pregnant women across age groups. In pregnancy, expected values change week by week and can span a range of tens of thousands of mIU/mL at any given gestational age, so your lab will report gestational-age-specific reference intervals alongside your result.

In pregnancy, hCG rises from undetectable to tens of thousands of mIU/mL within the first trimester, peaks around 8 to 10 weeks, and then declines. Multiple factors, including smoking, BMI, the number of prior pregnancies, ethnicity, and the sex of the fetus, all shift where your number falls within the expected range for any given week. A large study of over 8,000 pregnancies also showed that reference ranges differ depending on whether gestational age is dated by last menstrual period versus ultrasound.

Always compare your results within the same lab over time. Different laboratories use different tests that detect different combinations of hCG forms, and switching labs can produce meaningfully different numbers from the same blood sample.

When Results Can Be Misleading

The biggest source of confusion with hCG testing is not your biology but the test your lab uses. Different laboratory platforms detect different combinations of hCG forms (intact hCG, the free beta subunit, degradation fragments), which means the same blood sample can produce different numbers depending on which test is run. An evaluation of commercially available hCG laboratory tests found significant variability between platforms, particularly at high concentrations and in tumor-related samples. When tracking hCG over time, always use the same laboratory.

In cancer patients, hCG testing is especially prone to misinterpretation. Many tumors produce only the free beta subunit of hCG rather than the intact hormone, which can trigger a positive pregnancy test even when no pregnancy exists. A study at a cancer center found that 38% of positive total beta-hCG results in cancer patients were false positives for pregnancy. Switching to a test that specifically detects intact hCG reduced that false-positive rate to just 3%, without missing any real pregnancies.

Menopausal status is another common source of false alarms. If you are over 55 and a pregnancy test comes back mildly positive (under 14 mIU/mL), the cause is almost certainly normal pituitary production rather than pregnancy. Checking FSH alongside hCG can confirm this: a high FSH indicates menopausal pituitary activity, not pregnancy or a tumor.

Home pregnancy tests add another layer of variability. Testing found that detection thresholds across different devices ranged from 6.3 to 50 mIU/mL, and many devices performed poorly at detecting the earliest pregnancy form of hCG (called hyperglycosylated hCG), which is the dominant form in the first few days after implantation. A negative home test does not guarantee you are not pregnant if it is very early.

Why One Reading Is Not Enough

A single hCG value is a snapshot. The trajectory is the story. In early pregnancy, the rate of rise tells you far more about viability than any individual number. A level of 500 mIU/mL could be perfectly normal at 4 weeks or a warning sign at 6 weeks. Without a second measurement to establish the trend, the number alone is ambiguous.

If you are using hCG to confirm or monitor an early pregnancy, plan for at least two blood draws 48 to 72 hours apart, using the same lab. This is the minimum needed to calculate a doubling time and compare it against normal expectations. If you are tracking hCG after a pregnancy loss, molar pregnancy, or cancer treatment, your medical team will set a monitoring schedule, often weekly until levels become undetectable and then periodically for months. Research on trophoblastic disease surveillance suggests that long-term follow-up beyond several years after hCG normalization may not be necessary, as recurrences after that point are extremely rare.

For non-pregnant adults, a single mildly elevated result should be repeated before assuming it reflects a problem. Pituitary production, test interference, or sample handling can all produce a one-time elevation that does not recur. A second draw two to four weeks later at the same lab can confirm or rule out a true signal.

What to Do With Your Results

If your hCG is positive and you are trying to conceive, the most immediate next step is a repeat blood draw in 48 to 72 hours at the same lab to confirm the level is rising appropriately. Once hCG reaches approximately 1,500 to 2,000 mIU/mL, a transvaginal ultrasound should be able to visualize a gestational sac, confirming the pregnancy is located in the uterus.

If hCG is rising but slower than expected, your provider will want to rule out ectopic pregnancy. The combination of hCG trends and ultrasound findings guides the decision about whether to watch, intervene with medication, or proceed to surgery. A single slow-rising number is not an emergency, but it does demand follow-up rather than reassurance.

If hCG is unexpectedly positive and you are not trying to conceive, not of reproductive age, or male, the result warrants further investigation. Companion tests to consider include FSH (follicle stimulating hormone, to check for menopausal pituitary production), imaging of the chest and pelvis, and potentially AFP (alpha-fetoprotein, a protein that can be elevated in certain cancers) and LDH (lactate dehydrogenase, an enzyme released by damaged tissue) if a germ cell tumor is suspected. Referral to a gynecologic oncologist or reproductive endocrinologist depends on the clinical picture.